Clinical Trial Update: Long-Term Safety Study of Canagliflozin (TA-7284) in Combination With GLP-1 Analogue in Patients With Type 2 Diabetes Mellitus [Phase 4]

View source ↗

Summary

Phase 4 long-term safety study evaluating the combination of canagliflozin with a GLP-1 analogue in adults with type 2 diabetes mellitus has completed and poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Canagliflozin (canagliflozin)
• GLP-1 analogue (GLP-1 analogue)

Snippet

Sponsor: Tanabe Pharma Corporation | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED | Results posted: 2019-03-14